← 產業報告目錄

Anti-snoring Devices Market by Device Type (Oral Appliances, Nasal Devices, Position Control Devices), Gender (Male, Female), Age (Between 40-60, above 60), Distribution Channel (Online, Retail), End User (Homecare, Hospital) - Global Forecast to 2029

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-01-24頁數 280報告編號 MD3739

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

Global Anti-Snoring Devices Market Size is estimated to be about USD 0.91 Billion in 2024 and estimated to reach about USD 1.45 Billion by the year 2029, at a growth rate of CAGR of 9.8% during the forecasted period. The market is projected to expand due to the increasing prevalence of sleep disorders such as sleep apnea, advancements in sleep therapy technologies, and the growing elderly population, which often faces a higher risk of chronic diseases. However, growth may be constrained by the high costs associated with oral sleep appliances and the complexity of referral processes. Efforts led by government health initiatives and public awareness campaigns addressing sleep disorders are driving market growth further. Moreover, innovations in oral appliance technology and improved comfort features are enhancing patient compliance, encouraging adoption. Despite these positive factors, challenges like expensive devices and complicated diagnostic pathways may slow the growth rate. Nonetheless, the market is set to progress steadily, driven by a stronger focus on sleep health and greater accessibility to advanced treatment solutions. “The oral appliances segment accounted for the largest share of the market in 2023, by device type.” The anti-snoring devices market, categorized by device type, includes oral appliances, nasal devices, position control devices, chin straps, and EPAP therapy devices. In 2023, oral appliances held the largest market share, primarily due to the growing popularity of mandibular advancement devices (MADs). This dominance is supported by extensive research demonstrating their superior effectiveness compared to other anti-snoring solutions. “Home care settings segment dominated the anti-snoring devices market in 2023, based on end user.” Based on end users, the anti-snoring devices market is segmented into home care settings and hospitals & clinics. The home care settings segment accounted for the largest share of the anti-snoring devices market in 2023. The large share of this segment can be attributed to the increasing patient preference for home sleep testing and the growing number of advanced home sleep care devices available in the market. “Asia Pacific: The fastest-growing region in Anti-snoring devices market.” The worldwide market for Anti-snoring devices is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Notably, the Asia Pacific region is anticipated to experience the most substantial growth in the forecast period. Due to the high prevalence of symptomatic OSA among middle-aged men and women, the anti-snoring devices market in several Asia Pacific countries is expected to witness high growth during the forecast period. The large patient pool and population of undiagnosed patients indicate a massive potential for the Asia Pacific anti-snoring devices market. The regional and leading players have collaborated, signed several deals, and expanded their presence. Another major growth driver of this segment in the Anti-snoring devices market is the increasing healthcare expenditure, along with supportive regulatory frameworks. All these factors propel increased growth of the Anti-snoring devices market in the Asia Pacific region. The break-up of the profile of primary participants in the Anti-snoring devices market: • By Company Type: Tier 1 - 55%, Tier 2 - 25%, and Tier 3 – 20% • By Designation: M-level - 30%, D-level - 50%, and Others - 20% • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa- 2%, GCC Countries – 2% (Others-4%) The key players in this market are are ResMed (US), SomnoMed (Australia), ProSomnus Sleep Technologies (US), and Vivos Therapeutics, Inc. (US), DynaFlex (US), OpenAirway (Canada), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), OravanOSA (US), Myerson LLC. (US), Braebon Medical Corporation (Canada), MPowrx Health and Wellness Products (Canada), The Snore Reliever Company, LLC (US), Tomed GmbH (Germany), The Aurum Group (Canada), OSCIMED SA (Switzerland), SICAT GmbH & Co. KG (Germany), Glidewell (US), ApnoMed, Inc. (US), ZQuiet (US), among others. Research Coverage:  This research report categorizes the Anti-snoring devices market by device type (Mandibular Advancement Devices, Tongue-retaining Devices, Nasal Devices, Position Control Devices, Chin Straps, EPAP Therapy Devices ), by gender (male, female), by age (below 40, between 40 to 60, above 60), by distribution channel(online, retail, hospital), by end user (home care settings, hospitals & clinics), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa and GCC Countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the Anti-snoring devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches, and recent developments associated with the Anti-snoring devices market. Competitive analysis of upcoming startups in the Anti-snoring devices market ecosystem is covered in this report. Reasons to buy this report: The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Anti-snoring devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges. The report provides insights on the following pointers: • Analysis of key drivers (rising incidence of OSA and snoring population, and increased sleep devices technologies ) opportunities (Growth opportunities in emerging economies), restraints (high cost of devices, Unfavorable reimbursement scenario), and challenges (changing regulatory landscape) influencing the growth of the Anti-snoring devices market. • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the Anti-snoring devices market. • Market Development: Comprehensive information about lucrative markets – the report analyses the Anti-snoring devices market across varied regions. • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Anti-snoring devices market. • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like ResMed (US), SomnoMed (Australia), ProSomnus Sleep Technologies (US), and Vivos Therapeutics, Inc. (US), DynaFlex (US).
目錄 Table of Contents
1 INTRODUCTION 30 1.1 STUDY OBJECTIVES 30 1.2 MARKET DEFINITION 30 1.3 MARKET SCOPE 31 1.3.1 MARKET SEGMENTATION 31 1.3.2 INCLUSIONS & EXCLUSIONS 32 1.3.3 YEARS CONSIDERED 33 1.3.4 CURRENCY CONSIDERED 33 1.4 STAKEHOLDERS 33 1.5 SUMMARY OF CHANGES 34 2 RESEARCH METHODOLOGY 35 2.1 RESEARCH DATA 35 2.1.1 SECONDARY DATA 36 2.1.1.1 Key data from secondary sources 37 2.1.2 PRIMARY DATA 38 2.1.2.1 Primary sources 38 2.1.2.2 Key industry insights 39 2.1.2.3 Key data from primary sources 39 2.1.2.4 Breakdown of primary interviews 40 2.2 MARKET SIZE ESTIMATION 40 2.2.1 BOTTOM-UP APPROACH 41 2.2.1.1 Approach 1: Company revenue estimation approach 41 2.2.1.2 Approach 2: Presentations of companies and primary interviews 42 2.2.1.3 Approach 3: Patient-based approach 42 2.2.1.4 Growth forecast 43 2.2.1.5 CAGR projections 43 2.2.2 TOP-DOWN APPROACH 44 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 45 2.4 MARKET SHARE ASSUMPTIONS 46 2.5 STUDY ASSUMPTIONS 46 2.6 RESEARCH LIMITATIONS 46 2.7 RISK ASSESSMENT 47 3 EXECUTIVE SUMMARY 48 4 PREMIUM INSIGHTS 52 4.1 ANTI-SNORING DEVICES MARKET OVERVIEW 52 4.2 GEOGRAPHIC GROWTH OPPORTUNITIES 55 5 MARKET OVERVIEW 56 5.1 INTRODUCTION 56 5.2 MARKET DYNAMICS 56 5.2.1 DRIVERS 57 5.2.1.1 Growing prevalence of sleep disorders 57 5.2.1.2 Increasing geriatric population and subsequent rise in obesity 58 5.2.1.3 Growing cigarette & alcohol consumption 58 5.2.1.4 Rising technological advancements in anti-snoring devices 59 5.2.2 RESTRAINTS 60 5.2.2.1 High price of customized oral appliances 60 5.2.2.2 Unreliable efficacy and inadequate studies for utilization of anti-snoring devices 60 5.2.2.3 Social stigma associated with snoring 61 5.2.3 OPPORTUNITIES 61 5.2.3.1 Expanding undiagnosed population 61 5.2.3.2 High growth potential of emerging markets 62 5.2.4 CHALLENGES 62 5.2.4.1 Complex referral pathways and long waiting periods 62 5.3 PRICING ANALYSIS 63 5.3.1 AVERAGE SELLING PRICE OF ANTI-SNORING DEVICES, BY KEY PLAYER 63 5.3.2 AVERAGE SELLING PRICE TREND, BY DEVICE TYPE, 2021–2023 64 5.3.3 AVERAGE SELLING PRICE TREND OF ANTI-SNORING DEVICES (ORAL APPLIANCES), BY REGION, 2021–2023 (USD) 65 5.4 VALUE CHAIN ANALYSIS 65 5.5 SUPPLY CHAIN ANALYSIS 66 5.6 ECOSYSTEM ANALYSIS 67 5.6.1 ANTI-SNORING DEVICES MARKET: ROLE IN ECOSYSTEM 68 5.7 PORTER’S FIVE FORCES ANALYSIS 69 5.7.1 THREAT OF NEW ENTRANTS 70 5.7.2 THREAT OF SUBSTITUTES 70 5.7.3 BARGAINING POWER OF SUPPLIERS 70 5.7.4 BARGAINING POWER OF BUYERS 70 5.7.5 INTENSITY OF COMPETITIVE RIVALRY 70 5.8 REGULATORY ANALYSIS 71 5.8.1 REGULATORY LANDSCAPE 71 5.8.1.1 North America 71 5.8.1.1.1 US 71 5.8.1.1.1.1 Reimbursement scenario in US 72 5.8.1.1.2 Canada 73 5.8.1.2 Europe 73   5.8.1.3 Asia Pacific 74 5.8.1.3.1 Japan 74 5.8.1.3.2 China 74 5.8.1.3.3 India 75 5.8.1.3.4 Australia 76 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 5.8.2.1 North America 76 5.8.2.2 Europe 77 5.8.2.3 Asia Pacific 77 5.8.2.4 Latin America 78 5.8.2.5 Middle East & Africa 78 5.9 TECHNOLOGY ANALYSIS 79 5.9.1 KEY TECHNOLOGIES 79 5.9.1.1 Mandibular advancement devices 79 5.9.2 ADJACENT TECHNOLOGIES 79 5.9.2.1 Daytime-nighttime appliances 79 5.10 TRADE ANALYSIS 80 5.10.1 IMPORT DATA FOR HS CODE 901849, BY COUNTRY, 2019–2023 (USD MILLION) 80 5.10.2 EXPORT DATA FOR HS CODE 901849, BY COUNTRY, 2019–2023 (USD MILLION) 80 5.11 PATENT ANALYSIS 81 5.12 KEY CONFERENCES & EVENTS, 2024−2025 82 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 83 5.14 KEY STAKEHOLDERS & BUYING CRITERIA 83 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 83 5.14.2 BUYING CRITERIA 84 5.15 IMPACT OF AI/GENERATIVE AI ON ANTI-SNORING DEVICES MARKET 85 5.16 INVESTMENT & FUNDING SCENARIO 85 5.17 CASE STUDY ANALYSIS 86 6 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE 87 6.1 INTRODUCTION 88 6.2 ORAL APPLIANCES 88 6.2.1 MANDIBULAR ADVANCEMENT DEVICES 93 6.2.1.1 Ready-made mandibular advancement devices 96 6.2.1.1.1 Low cost to fuel uptake 96 6.2.1.2 Custom-made mandibular advancement devices 98 6.2.1.2.1 High efficacy to drive market 98 6.3 TONGUE-RETAINING/STABILIZING DEVICES 101 6.3.1 LOWER SUCCESS RATE OF TRDS TO RESTRAIN MARKET 101   6.4 NASAL DEVICES 103 6.4.1 EXTERNAL NASAL DILATORS 105 6.4.1.1 Convenient and non-invasive benefits to boost demand 105 6.4.2 OTHER NASAL DEVICES 107 6.5 POSITION CONTROL DEVICES 110 6.6 CHIN STRAPS 112 6.7 EPAP THERAPY DEVICES 114 7 ANTI-SNORING DEVICES MARKET, BY GENDER 117 7.1 INTRODUCTION 118 7.2 MALE PATIENTS 119 7.2.1 HIGHER PREVALENCE OF OSA OWING TO ANATOMY VARIATIONS TO PROPEL MARKET 119 7.3 FEMALE PATIENTS 121 7.3.1 RISING CASES OF UNDIAGNOSED OSA TO DRIVE MARKET 121 8 ANTI-SNORING DEVICES MARKET, BY AGE GROUP 123 8.1 INTRODUCTION 124 8.2 BELOW 40 YEARS 125 8.2.1 LOW PREVALENCE OF OSA AMONG YOUNGER INDIVIDUALS TO RESTRAIN MARKET 125 8.3 BETWEEN 40–60 YEARS 127 8.3.1 INCREASING INCIDENCE OF CVD AND HYPERTENSION TO PROPEL MARKET 127 8.4 ABOVE 60 YEARS 129 8.4.1 CHANGING SLEEPING PATTERNS TO SUPPORT MARKET GROWTH 129 9 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL 132 9.1 INTRODUCTION 133 9.2 ONLINE PHARMACIES 133 9.2.1 GROWING PREFERENCE FOR DIRECT DISTRIBUTION CHANNELS TO DRIVE MARKET 133 9.3 RETAIL PHARMACIES 136 9.3.1 CONVENIENT ACCESSIBILITY TO PRODUCTS TO PROPEL MARKET 136 9.4 HOSPITAL PHARMACIES 138 9.4.1 GROWING FOCUS ON PATIENT CONVENIENCE TO FUEL UPTAKE 138 10 ANTI-SNORING DEVICES MARKET, BY END USER 140 10.1 INTRODUCTION 141 10.2 HOME CARE SETTINGS 141 10.2.1 GROWING PATIENT PREFERENCE FOR ADVANCED SLEEP MONITORING DEVICES TO PROPEL MARKET 141 10.3 HOSPITALS & CLINICS 143 10.3.1 RAPID DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET 143 11 ANTI-SNORING DEVICES MARKET, BY REGION 146 11.1 INTRODUCTION 147 11.2 NORTH AMERICA 148 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 148 11.2.2 US 153 11.2.2.1 Rising trend of remote sleep testing to fuel uptake 153 11.2.3 CANADA 157 11.2.3.1 Increasing number of research grants for sleep apnea devices to boost demand 157 11.3 EUROPE 160 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 161 11.3.2 GERMANY 164 11.3.2.1 High prevalence of smoking to boost demand 164 11.3.3 UK 168 11.3.3.1 Rising awareness and increasing number of sleep service groups to support market growth 168 11.3.4 FRANCE 171 11.3.4.1 Rising geriatric population to fuel uptake 171 11.3.5 ITALY 175 11.3.5.1 Favorable initiatives for treatment of OSA to support market growth 175 11.3.6 SPAIN 178 11.3.6.1 Increasing initiatives for social awareness by regional organizations for treatment to drive market 178 11.3.7 REST OF EUROPE 181 11.4 ASIA PACIFIC 185 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 185 11.4.2 CHINA 190 11.4.2.1 Growing adult obesity rates and expanding geriatric population to propel market 190 11.4.3 JAPAN 193 11.4.3.1 Rising demand for cloud-connected OSA therapy devices to boost demand 193 11.4.4 AUSTRALIA 196 11.4.4.1 Rising R&D initiatives for innovative sleep therapy devices to boost demand 196 11.4.5 REST OF ASIA PACIFIC 199 11.5 LATIN AMERICA 203 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 203 11.5.2 BRAZIL 207 11.5.2.1 Favorable reimbursement policies for advanced sleep apnea procedures to drive market 207 11.5.3 MEXICO 210 11.5.3.1 Poor healthcare infrastructure to limit market growth 210 11.5.4 REST OF LATIN AMERICA 213 11.6 MIDDLE EAST & AFRICA 216 11.6.1 PRESENCE OF GLOBAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET 216 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 217 11.7 GCC COUNTRIES 220 11.7.1 HIGH OBESITY RATES TO SUPPORT MARKET GROWTH 220 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 221 12 COMPETITIVE LANDSCAPE 225 12.1 OVERVIEW 225 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 225 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ANTI-SNORING DEVICES MARKET 225 12.3 REVENUE ANALYSIS, 2019–2023 227 12.4 MARKET SHARE ANALYSIS, 2023 228 12.4.1 RANKING OF KEY MARKET PLAYERS 230 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 230 12.5.1 STARS 230 12.5.2 EMERGING LEADERS 230 12.5.3 PERVASIVE PLAYERS 230 12.5.4 PARTICIPANTS 230 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 232 12.5.5.1 Company footprint 232 12.5.5.2 Region footprint 233 12.5.5.3 Device footprint 234 12.5.5.4 Distribution channel footprint 234 12.5.5.5 End-user footprint 235 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 235 12.6.1 PROGRESSIVE COMPANIES 235 12.6.2 RESPONSIVE COMPANIES 235 12.6.3 DYNAMIC COMPANIES 236 12.6.4 STARTING BLOCKS 236 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 237 12.7 COMPANY VALUATION & FINANCIAL METRICS 238 12.7.1 FINANCIAL METRICS 238 12.7.2 COMPANY VALUATION 238 12.8 BRAND/PRODUCT COMPARISON 239 12.9 COMPETITIVE SCENARIO 240 12.9.1 PRODUCT LAUNCHES & APPROVALS 240 12.9.2 DEALS 241 12.9.3 EXPANSIONS 242 12.9.4 OTHER DEVELOPMENTS 242 13 COMPANY PROFILES 243 13.1 KEY PLAYERS 243 13.1.1 RESMED 243 13.1.1.1 Business overview 243 13.1.1.2 Products offered 245 13.1.1.3 Recent developments 245 13.1.1.3.1 Deals 245 13.1.1.3.2 Expansions 246 13.1.1.4 MnM view 246 13.1.1.4.1 Key strengths 246 13.1.1.4.2 Strategic choices 246 13.1.1.4.3 Weaknesses & competitive threats 246 13.1.2 SOMNOMED 247 13.1.2.1 Business overview 247 13.1.2.2 Products offered 248 13.1.2.3 MnM view 248 13.1.2.3.1 Key strengths 248 13.1.2.3.2 Strategic choices 248 13.1.2.3.3 Weaknesses & competitive threats 248 13.1.3 PROSOMNUS SLEEP TECHNOLOGIES 249 13.1.3.1 Business overview 249 13.1.3.2 Products offered 250 13.1.3.3 Recent developments 250 13.1.3.3.1 Deals 250 13.1.3.4 MnM view 250 13.1.3.4.1 Key strengths 250 13.1.3.4.2 Strategic choices 250 13.1.3.4.3 Weaknesses & competitive threats 251 13.1.4 VIVOS THERAPEUTICS, INC. 252 13.1.4.1 Business overview 252 13.1.4.2 Products offered 253 13.1.4.3 Recent developments 253 13.1.4.3.1 Product approvals 253 13.1.4.3.2 Deals 253 13.1.4.3.3 Expansions 254 13.1.4.3.4 Other developments 254 13.1.5 DYNAFLEX 255 13.1.5.1 Business overview 255 13.1.5.2 Products offered 255 13.1.5.3 Recent developments 256 13.1.5.3.1 Deals 256   13.1.6 OPENAIRWAY 257 13.1.6.1 Business overview 257 13.1.6.2 Products offered 257 13.1.6.3 Recent developments 257 13.1.6.3.1 Deals 257 13.1.7 PANTHERA DENTAL 258 13.1.7.1 Business overview 258 13.1.7.2 Products offered 258 13.1.7.3 Recent developments 258 13.1.7.3.1 Product launches 258 13.1.7.3.2 Deals 259 13.1.7.3.3 Other developments 259 13.1.8 AIRWAY MANAGEMENT 260 13.1.8.1 Business overview 260 13.1.8.2 Products offered 260 13.1.8.3 Recent developments 260 13.1.8.3.1 Product launches 260 13.1.9 APNEA SCIENCES 261 13.1.9.1 Business overview 261 13.1.9.2 Products offered 261 13.1.10 ORAVANOSA 262 13.1.10.1 Business overview 262 13.1.10.2 Products offered 262 13.1.11 MYERSON LLC 263 13.1.11.1 Business overview 263 13.1.11.2 Products offered 263 13.1.12 BRAEBON MEDICAL CORPORATION 264 13.1.12.1 Business overview 264 13.1.12.2 Products offered 264 13.2 OTHER PLAYERS 265 13.2.1 MPOWRX HEALTH & WELLNESS PRODUCTS 265 13.2.2 THE SNORE RELIEVER COMPANY, LLC 265 13.2.3 TOMED GMBH 266 13.2.4 THE AURUM GROUP 266 13.2.5 OSCIMED SA 267 13.2.6 SICAT GMBH & CO. KG 267 13.2.7 GLIDEWELL 268 13.2.8 APNOMED, INC. 269 13.2.9 ZQUIET 269 13.2.10 DREAM SYSTEMS DENTAL SLEEP LAB 270   13.2.11 PURE SLEEP COMPANY 270 13.2.12 THERAVENT, INC. 271 13.2.13 INNOVATIVE HEALTH TECHNOLOGIES 271 14 APPENDIX 272 14.1 DISCUSSION GUIDE 272 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 276 14.3 CUSTOMIZATION OPTIONS 278 14.4 RELATED REPORTS 278 14.5 AUTHOR DETAILS 279
圖表清單 List of Tables & Figures
TABLE 1 ANTI-SNORING DEVICES MARKET: INCLUSIONS & EXCLUSIONS 32 TABLE 2 ANTI-SNORING DEVICES MARKET: RISK ASSESSMENT ANALYSIS 47 TABLE 3 PREVALENCE OF SLEEP APNEA, BY COUNTRY, 2022–2024 57 TABLE 4 KEY STATISTICS ON AGING POPULATION 58 TABLE 5 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SNORING 59 TABLE 6 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA AND SNORING 59 TABLE 7 INADEQUATE EFFICACY STUDIES ASSOCIATED WITH USE OF ANTI-SNORING DEVICES 61 TABLE 8 KEY STATISTICS ON SNORING POPULATION 61 TABLE 9 HIGH GROWTH POTENTIAL IN EMERGING MARKETS DUE TO UNDIAGNOSED POPULATION 62 TABLE 10 AVERAGE SELLING PRICE OF ANTI-SNORING DEVICES, BY KEY PLAYER 63 TABLE 11 AVERAGE SELLING PRICE TREND, BY DEVICE TYPE, 2021–2023 64 TABLE 12 AVERAGE SELLING PRICE TREND OF ANTI-SNORING DEVICES (ORAL APPLIANCES), BY REGION, 2021–2023 (USD) 65 TABLE 13 ANTI-SNORING DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 69 TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 72 TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 73 TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 74 TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES 75 TABLE 18 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 19 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 20 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 21 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 22 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 23 ANTI-SNORING DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2024−2025 82 TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ANTI-SNORING DEVICES (%) 84 TABLE 25 KEY BUYING CRITERIA FOR END USERS OF ANTI-SNORING DEVICES 84 TABLE 26 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 88 TABLE 27 ORAL APPLIANCES OFFERED BY KEY PLAYERS 89 TABLE 28 ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 89 TABLE 29 ORAL APPLIANCES MARKET, BY REGION, 2022–2029 (USD MILLION) 90 TABLE 30 NORTH AMERICA: ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 90 TABLE 31 NORTH AMERICA: ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (THOUSAND UNITS) 90 TABLE 32 EUROPE ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 91 TABLE 33 EUROPE: ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (THOUSAND UNITS) 91 TABLE 34 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 92 TABLE 35 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (THOUSAND UNITS) 92 TABLE 36 LATIN AMERICA: ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 92 TABLE 37 MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS 93 TABLE 38 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 94 TABLE 39 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 94 TABLE 40 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 94 TABLE 41 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 95 TABLE 42 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 95 TABLE 43 LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 95 TABLE 44 READY-MADE MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS 96 TABLE 45 READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 96 TABLE 46 NORTH AMERICA: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 97 TABLE 47 EUROPE: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 97 TABLE 48 ASIA PACIFIC: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 97 TABLE 49 LATIN AMERICA: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 98 TABLE 50 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS 98 TABLE 51 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 99 TABLE 52 NORTH AMERICA: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 99 TABLE 53 EUROPE: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 100 TABLE 54 ASIA PACIFIC: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 100 TABLE 55 LATIN AMERICA: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 100 TABLE 56 TONGUE-RETAINING DEVICES OFFERED BY KEY PLAYERS 101 TABLE 57 TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 101 TABLE 58 NORTH AMERICA: TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 102 TABLE 59 EUROPE: TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 102 TABLE 60 ASIA PACIFIC: TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 102 TABLE 61 LATIN AMERICA: TONGUE-RETAINING/STABILIZING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 103 TABLE 62 NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 103 TABLE 63 NASAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 104 TABLE 64 NORTH AMERICA: NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 104 TABLE 65 EUROPE: NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 104 TABLE 66 ASIA PACIFIC: NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 105 TABLE 67 LATIN AMERICA: NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 105 TABLE 68 EXTERNAL NASAL DILATORS MARKET, BY REGION, 2022–2029 (USD MILLION) 106 TABLE 69 NORTH AMERICA: EXTERNAL NASAL DILATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 106 TABLE 70 EUROPE: EXTERNAL NASAL DILATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 106 TABLE 71 ASIA PACIFIC: EXTERNAL NASAL DILATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 107 TABLE 72 LATIN AMERICA: EXTERNAL NASAL DILATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 107 TABLE 73 OTHER NASAL DEVICES 108 TABLE 74 OTHER NASAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 108 TABLE 75 NORTH AMERICA: OTHER NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 109 TABLE 76 EUROPE: OTHER NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 109 TABLE 77 ASIA PACIFIC: OTHER NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 109 TABLE 78 LATIN AMERICA: OTHER NASAL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 110 TABLE 79 POSITION CONTROL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 110 TABLE 80 NORTH AMERICA: POSITION CONTROL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 111 TABLE 81 EUROPE: POSITION CONTROL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 111 TABLE 82 ASIA PACIFIC: POSITION CONTROL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 111 TABLE 83 LATIN AMERICA: POSITION CONTROL DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 112 TABLE 84 CHIN STRAPS MARKET, BY REGION, 2022–2029 (USD MILLION) 112 TABLE 85 NORTH AMERICA: CHIN STRAPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113 TABLE 86 EUROPE: CHIN STRAPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113 TABLE 87 ASIA PACIFIC: CHIN STRAPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113 TABLE 88 LATIN AMERICA: CHIN STRAPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 114 TABLE 89 EPAP THERAPY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 114 TABLE 90 NORTH AMERICA: EPAP THERAPY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 115 TABLE 91 EUROPE: EPAP THERAPY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 115 TABLE 92 ASIA PACIFIC: EPAP THERAPY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 115 TABLE 93 LATIN AMERICA: EPAP THERAPY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 116 TABLE 94 PREVALENCE OF SLEEP APNEA, BY AGE GROUP AND GENDER 118 TABLE 95 ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 118 TABLE 96 ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY REGION, 2022–2029 (USD MILLION) 119 TABLE 97 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 119 TABLE 98 EUROPE: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 120 TABLE 99 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 120 TABLE 100 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 120 TABLE 101 ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY REGION, 2022–2029 (USD MILLION) 121 TABLE 102 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 121 TABLE 103 EUROPE: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 122 TABLE 104 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 122 TABLE 105 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 122 TABLE 106 PREVALENCE OF SLEEP APNEA, BY AGE GROUP (2022) 124 TABLE 107 ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 124 TABLE 108 ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY REGION, 2022–2029 (USD MILLION) 125 TABLE 109 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 125 TABLE 110 EUROPE: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 126 TABLE 111 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 126 TABLE 112 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS UNDER 40 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 127 TABLE 113 ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY REGION, 2022–2029 (USD MILLION) 127 TABLE 114 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 128 TABLE 115 EUROPE: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 128 TABLE 116 ASIA PACIFIC: 40–60 YEARS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 128 TABLE 117 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 129 TABLE 118 ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY REGION, 2022–2029 (USD MILLION) 129 TABLE 119 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 130 TABLE 120 EUROPE: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 130 TABLE 121 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 130 TABLE 122 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022–2029 (USD MILLION) 131 TABLE 123 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 133 TABLE 124 ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY REGION, 2022–2029 (USD MILLION) 134 TABLE 125 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 134 TABLE 126 EUROPE: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 135 TABLE 127 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 135 TABLE 128 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 135 TABLE 129 ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY REGION, 2022–2029 (USD MILLION) 136 TABLE 130 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 136 TABLE 131 EUROPE: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 137 TABLE 132 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 137 TABLE 133 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 137 TABLE 134 ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2022–2029 (USD MILLION) 138 TABLE 135 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 138 TABLE 136 EUROPE: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 139 TABLE 137 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 139 TABLE 138 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION) 139 TABLE 139 ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 141 TABLE 140 ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2029 (USD MILLION) 141 TABLE 141 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 142 TABLE 142 EUROPE: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 142 TABLE 143 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 142 TABLE 144 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 143 TABLE 145 ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2029 (USD MILLION) 144 TABLE 146 NORTH AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 144 TABLE 147 EUROPE: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 145 TABLE 148 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 145 TABLE 149 LATIN AMERICA: ANTI-SNORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 145 TABLE 150 ANTI-SNORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 147 TABLE 151 NORTH AMERICA: MACROECONOMIC INDICATORS 148 TABLE 152 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150 TABLE 153 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 150 TABLE 154 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 150 TABLE 155 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 151 TABLE 156 NORTH AMERICA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 151 TABLE 157 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 151 TABLE 158 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 152 TABLE 159 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 152 TABLE 160 NORTH AMERICA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 152 TABLE 161 KEY ANTI-SNORING PRODUCTS PROVIDED BY LEADING PLAYERS IN US 154 TABLE 162 US: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 154 TABLE 163 US: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 154 TABLE 164 US: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 155 TABLE 165 US: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 155 TABLE 166 US: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 155 TABLE 167 US: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 156 TABLE 168 US: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 156 TABLE 169 US: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 156 TABLE 170 KEY ANTI-SNORING PRODUCTS PROVIDED BY LEADING PLAYERS IN CANADA 157 TABLE 171 CANADA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 158 TABLE 172 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 158 TABLE 173 CANADA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 158 TABLE 174 CANADA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 159 TABLE 175 CANADA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 159 TABLE 176 CANADA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 159 TABLE 177 CANADA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 160 TABLE 178 CANADA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 160 TABLE 179 EUROPE: MACROECONOMIC INDICATORS 161 TABLE 180 EUROPE: ANTI-SNORING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161 TABLE 181 EUROPE: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 162 TABLE 182 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 162 TABLE 183 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 162 TABLE 184 EUROPE: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 163 TABLE 185 EUROPE: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 163 TABLE 186 EUROPE: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 163 TABLE 187 EUROPE: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 164 TABLE 188 EUROPE: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 164 TABLE 189 ANTI-SNORING PRODUCTS PROVIDED BY LEADING PLAYERS IN GERMANY 165 TABLE 190 GERMANY: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 165 TABLE 191 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 166 TABLE 192 GERMANY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 166 TABLE 193 GERMANY: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 166 TABLE 194 GERMANY: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 167 TABLE 195 GERMANY: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 167 TABLE 196 GERMANY: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 167 TABLE 197 GERMANY: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 168 TABLE 198 UK: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 169 TABLE 199 UK: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 169 TABLE 200 UK: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 169 TABLE 201 UK: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 170 TABLE 202 UK: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 170 TABLE 203 UK: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 170 TABLE 204 UK: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 171 TABLE 205 UK: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 171 TABLE 206 MAJOR PLAYERS THAT ARE REIMBURSED BY SOCIAL SECURITY OF FRANCE 172 TABLE 207 FRANCE: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 172 TABLE 208 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 172 TABLE 209 FRANCE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 173 TABLE 210 FRANCE: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 173 TABLE 211 FRANCE: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 173 TABLE 212 FRANCE: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 174 TABLE 213 FRANCE: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 174 TABLE 214 FRANCE: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 174 TABLE 215 ITALY: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 175 TABLE 216 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 176 TABLE 217 ITALY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 176 TABLE 218 ITALY: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 176 TABLE 219 ITALY: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 177 TABLE 220 ITALY: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 177 TABLE 221 ITALY: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 177 TABLE 222 ITALY: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 178 TABLE 223 SPAIN: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 179 TABLE 224 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 179 TABLE 225 SPAIN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 179 TABLE 226 SPAIN: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 180 TABLE 227 SPAIN: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 180 TABLE 228 SPAIN: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 180 TABLE 229 SPAIN: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 181 TABLE 230 SPAIN: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 181 TABLE 231 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 182 TABLE 232 REST OF EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 182 TABLE 233 REST OF EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 182 TABLE 234 REST OF EUROPE: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 183 TABLE 235 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 183 TABLE 236 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 183 TABLE 237 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 184 TABLE 238 REST OF EUROPE: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 184 TABLE 239 ASIA PACIFIC: MACROECONOMIC INDICATORS 185 TABLE 240 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 187 TABLE 241 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 187 TABLE 242 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 187 TABLE 243 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 188 TABLE 244 ASIA PACIFIC: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 188 TABLE 245 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 188 TABLE 246 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 189 TABLE 247 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 189 TABLE 248 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 189 TABLE 249 CHINA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 190 TABLE 250 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 191 TABLE 251 CHINA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 191 TABLE 252 CHINA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 191 TABLE 253 CHINA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 192 TABLE 254 CHINA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 192 TABLE 255 CHINA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 192 TABLE 256 CHINA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 193 TABLE 257 JAPAN: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 193 TABLE 258 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 194 TABLE 259 JAPAN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 194 TABLE 260 JAPAN: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 194 TABLE 261 JAPAN: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 195 TABLE 262 JAPAN: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 195 TABLE 263 JAPAN: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 195 TABLE 264 JAPAN: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 196 TABLE 265 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 197 TABLE 266 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 197 TABLE 267 AUSTRALIA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 197 TABLE 268 AUSTRALIA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 198 TABLE 269 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 198 TABLE 270 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 198 TABLE 271 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 199 TABLE 272 AUSTRALIA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 199 TABLE 273 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 200 TABLE 274 REST OF ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 200 TABLE 275 REST OF ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 201 TABLE 276 REST OF ASIA PACIFIC: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 201 TABLE 277 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 201 TABLE 278 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 202 TABLE 279 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 202 TABLE 280 REST OF ASIA PACIFIC: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 202 TABLE 281 LATIN AMERICA: MACROECONOMIC INDICATORS 203 TABLE 282 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 204 TABLE 283 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 204 TABLE 284 LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 205 TABLE 285 LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 205 TABLE 286 LATIN AMERICA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 205 TABLE 287 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 206 TABLE 288 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 206 TABLE 289 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, B Y DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 206 TABLE 290 LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 207 TABLE 291 BRAZIL: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 208 TABLE 292 BRAZIL: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 208 TABLE 293 BRAZIL: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 208 TABLE 294 BRAZIL: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 209 TABLE 295 BRAZIL: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 209 TABLE 296 BRAZIL: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 209 TABLE 297 BRAZIL: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 210 TABLE 298 BRAZIL: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 210 TABLE 299 MEXICO: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 211 TABLE 300 MEXICO: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 211 TABLE 301 MEXICO: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 211 TABLE 302 MEXICO: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 212 TABLE 303 MEXICO: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 212 TABLE 304 MEXICO: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 212 TABLE 305 MEXICO: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 213 TABLE 306 MEXICO: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 213 TABLE 307 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 214 TABLE 308 REST OF LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 214 TABLE 309 REST OF LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 214 TABLE 310 REST OF LATIN AMERICA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 215 TABLE 311 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 215 TABLE 312 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 215 TABLE 313 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 216 TABLE 314 REST OF LATIN AMERICA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 216 TABLE 315 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 217 TABLE 316 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 217 TABLE 317 MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 218 TABLE 318 MIDDLE EAST & AFRICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 218 TABLE 319 MIDDLE EAST & AFRICA: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 218 TABLE 320 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 219 TABLE 321 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 219 TABLE 322 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 219 TABLE 323 MIDDLE EAST & AFRICA: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 220 TABLE 324 GCC COUNTRIES: MACROECONOMIC INDICATORS 221 TABLE 325 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2022–2029 (USD MILLION) 221 TABLE 326 GCC COUNTRIES: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION) 222 TABLE 327 GCC COUNTRIES: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 222 TABLE 328 GCC COUNTRIES: NASAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 222 TABLE 329 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION) 223 TABLE 330 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 223 TABLE 331 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION) 223 TABLE 332 GCC COUNTRIES: ANTI-SNORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 224 TABLE 333 OVERVIEW OF STRATEGIES DEPLOYED BY KEY ANTI-SNORING DEVICE MANUFACTURING COMPANIES 225 TABLE 334 ANTI-SNORING DEVICES MARKET: DEGREE OF COMPETITION 229 TABLE 335 ANTI-SNORING DEVICES MARKET: REGION FOOTPRINT 233 TABLE 336 ANTI-SNORING DEVICES MARKET: DEVICE FOOTPRINT 234 TABLE 337 ANTI-SNORING DEVICES MARKET: DISTRIBUTION CHANNEL FOOTPRINT 234 TABLE 338 ANTI-SNORING DEVICES MARKET: END-USER FOOTPRINT 235 TABLE 339 ANTI-SNORING DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 237 TABLE 340 ANTI-SNORING DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 237 TABLE 341 ANTI-SNORING DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–NOVEMBER 2024 240 TABLE 342 ANTI-SNORING DEVICES MARKET: DEALS, JANUARY 2021–NOVEMBER 2024 241 TABLE 343 ANTI-SNORING DEVICES MARKET: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 242 TABLE 344 ANTI-SNORING DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024 242 TABLE 345 RESMED: COMPANY OVERVIEW 243 TABLE 346 RESMED: PRODUCTS OFFERED 245 TABLE 347 RESMED: DEALS, JANUARY 2021–NOVEMBER 2024 245 TABLE 348 RESMED: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 246 TABLE 349 SOMNOMED: COMPANY OVERVIEW 247 TABLE 350 SOMNOMED: PRODUCTS OFFERED 248   TABLE 351 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY OVERVIEW 249 TABLE 352 PROSOMNUS SLEEP TECHNOLOGIES: PRODUCTS OFFERED 250 TABLE 353 PROSOMNUS SLEEP TECHNOLOGIES: DEALS, JANUARY 2021–NOVEMBER 2024 250 TABLE 354 VIVOS THERAPEUTICS, INC.: COMPANY OVERVIEW 252 TABLE 355 VIVOS THERAPEUTICS, INC.: PRODUCTS OFFERED 253 TABLE 356 VIVOS THERAPEUTICS, INC.: PRODUCT APPROVALS, JANUARY 2021–MARCH 2024 253 TABLE 357 VIVOS THERAPEUTICS, INC.: DEALS, JANUARY 2021–NOVEMBER 2024 253 TABLE 358 VIVOS THERAPEUTICS, INC.: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 254 TABLE 359 VIVOS THERAPEUTICS, INC.: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024 254 TABLE 360 DYNAFLEX: COMPANY OVERVIEW 255 TABLE 361 DYNAFLEX: PRODUCTS OFFERED 255 TABLE 362 DYNAFLEX: DEALS, JANUARY 2021–NOVEMBER 2024 256 TABLE 363 OPENAIRWAY: COMPANY OVERVIEW 257 TABLE 364 OPENAIRWAY: PRODUCTS OFFERED 257 TABLE 365 OPENAIRWAY: DEALS, JANUARY 2021–NOVEMBER 2024 257 TABLE 366 PANTHERA DENTAL: COMPANY OVERVIEW 258 TABLE 367 PANTHERA DENTAL: PRODUCTS OFFERED 258 TABLE 368 PANTHERA DENTAL: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 258 TABLE 369 PANTHERA DENTAL: DEALS, JANUARY 2021–NOVEMBER 2024 259 TABLE 370 PANTHERA DENTAL: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024 259 TABLE 371 AIRWAY MANAGEMENT: COMPANY OVERVIEW 260 TABLE 372 AIRWAY MANAGEMENT: PRODUCTS OFFERED 260 TABLE 373 AIRWAY MANAGEMENT: PRODUCT LAUNCHES, JANUARY 2021−NOVEMBER 2024 260 TABLE 374 APNEA SCIENCES: COMPANY OVERVIEW 261 TABLE 375 APNEA SCIENCES: PRODUCTS OFFERED 261 TABLE 376 ORAVANOSA: COMPANY OVERVIEW 262 TABLE 377 ORAVANOSA: PRODUCTS OFFERED 262 TABLE 378 MYERSON LLC: COMPANY OVERVIEW 263 TABLE 379 MYERSON LLC: PRODUCTS OFFERED 263 TABLE 380 BRAEBON MEDICAL CORPORATION: COMPANY OVERVIEW 264 TABLE 381 BRAEBON MEDICAL CORPORATION: PRODUCTS OFFERED 264 FIGURE 1 MARKETS & REGIONS COVERED 31 FIGURE 2 ANTI-SNORING DEVICES MARKET: RESEARCH DESIGN 35 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 40 FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 41 FIGURE 5 BOTTOM-UP APPROACH: PATIENT-BASED ANALYSIS 42 FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 43 FIGURE 7 ANTI-SNORING DEVICES MARKET: TOP-DOWN APPROACH 44 FIGURE 8 DATA TRIANGULATION METHODOLOGY 45 FIGURE 9 ANTI-SNORING DEVICES MARKET: STUDY ASSUMPTIONS 46 FIGURE 10 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2024 VS. 2029 (USD MILLION) 48 FIGURE 11 ANTI-SNORING DEVICES MARKET, BY GENDER, 2024 VS. 2029 (USD MILLION) 49 FIGURE 12 ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION) 49 FIGURE 13 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD MILLION) 50 FIGURE 14 ANTI-SNORING DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 50 FIGURE 15 ANTI-SNORING DEVICES MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 51 FIGURE 16 INCREASING INCIDENCE OF SLEEP DISORDERS TO PROPEL MARKET 52 FIGURE 17 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE, 2024 VS. 2029 (USD MILLION) 52 FIGURE 18 ORAL APPLIANCES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 53 FIGURE 19 ANTI-SNORING DEVICES MARKET, BY GENDER, 2024 VS. 2029 (USD MILLION) 53 FIGURE 20 ANTI-SNORING DEVICES MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION) 54 FIGURE 21 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD MILLION) 54 FIGURE 22 ANTI-SNORING DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 55 FIGURE 23 ANTI-SNORING DEVICES MARKET: ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 55 FIGURE 24 ANTI-SNORING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56 FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES 65 FIGURE 26 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION IS THE PREFERRED STRATEGY OF PROMINENT COMPANIES 67 FIGURE 27 ANTI-SNORING DEVICES MARKET: ECOSYSTEM ANALYSIS 68 FIGURE 28 ANTI-SNORING DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 69 FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ANTI-SNORING DEVICES PATENTS, JANUARY 2014—MARCH 2024 81 FIGURE 30 ANTI-SNORING DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 83 FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ANTI-SNORING DEVICES 83 FIGURE 32 KEY BUYING CRITERIA FOR END USERS OF ANTI-SNORING DEVICES 84 FIGURE 33 ANTI-SNORING DEVICES MARKET: INVESTMENT & FUNDING SCENARIO FOR KEY PLAYERS (2019−2024) 85   FIGURE 34 NORTH AMERICA: ANTI-SNORING DEVICES MARKET SNAPSHOT 149 FIGURE 35 ASIA PACIFIC: ANTI-SNORING DEVICES MARKET SNAPSHOT 186 FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN ANTI-SNORING DEVICES MARKET, 2021−2023 (USD MILLION) 227 FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ANTI-SNORING DEVICES MARKET (2023) 228 FIGURE 38 RANKING OF KEY PLAYERS IN ANTI-SNORING DEVICES MARKET, 2023 230 FIGURE 39 ANTI-SNORING DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 231 FIGURE 40 ANTI-SNORING DEVICES MARKET: COMPANY FOOTPRINT 232 FIGURE 41 ANTI-SNORING DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 236 FIGURE 42 EV/EBITDA OF KEY VENDORS 238 FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 238 FIGURE 44 ANTI-SNORING DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 239 FIGURE 45 RESMED: COMPANY SNAPSHOT (2024) 244 FIGURE 46 SOMNOMED: COMPANY SNAPSHOT (2023) 247 FIGURE 47 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2023) 249 FIGURE 48 VIVOS THERAPEUTICS, INC.: COMPANY SNAPSHOT (2023) 252

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們